Efficacy of SUN N4057 in Subjects With Acute Ischemic Stroke and Measurable Penumbra on Magnetic Resonance Imaging (MRI)

PHASE2TerminatedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

October 31, 2006

Study Completion Date

January 31, 2007

Conditions
Stroke
Interventions
DRUG

piclozotan low dose

Continuous IV infusion over a period of up to 72 hours of piclozotan

DRUG

placebo

Continuous IV infusion over a period of up to 72 hours of placebo.

DRUG

piclozotan high dose

Continuous IV infusion over a period of up to 72 hours of piclozotan

Trial Locations (47)

2020

General Hospital Middelheim, Dept. of Neurology, Antwerp

2157

Sunninghill Hospital Cnr., Sunninghill

3000

Uz Gasthuisberg, Neurology, Leuven

4001

St Augustines Hospital, Durban

7130

Vergelegen Medi-Clinic, Somerset West

11794

SUNY at Stony Brook, University Hospital at Stony Brook, Stony Brook

17007

University Hospital of Girona Dr. Josep Trueta, Neurology Department, Girona

22042

INOVA Research Center, Falls Church

25304

Charleston Area Medical Center Health Education and Research Institute, Charleston

27103

Clinical Research Center of Winston-Salem, Winston-Salem

27401

Moses Cone Hospital, Greensboro

31096

Rambam Medical Center, Haifa

33805

Lakeland Regional Medical Center, Lakeland

34471

OCALA Neurodiagnostic Center, Ocala

37404

Chattanooga Neurology Associates, Chattanooga

38104

Methodist University Hospital, Memphis

40536

University of Kentucky, Sanders Brown Center on Aging/Stroke Program, Lexington

41013

Hospitales Universitarios Virgen Del Rocio, Seville

44309

Summa Health System Neurology and Neuroscience Associates, Akron

48201

Wayne State University, Detroit

48824

Michigan State University, Sparrow Health System, East Lansing

50314

Ruan Neurology Clinic and Clinical Research Center, Des Moines

52621

Chaim Sheba Medical Center, Tel Litwinsky

53226

Medical College of Wisconsin, Milwaukee

59405

Advance Neurology Specialists, Great Falls

62702

Southern Illinois University School of Medicine, Springfield

64111

St. Luke's Hospital, Kansas City

64239

Tel-Aviv Sourasky Medical Center, Tel Aviv

67214

Via Christi Regional Medical Center, Wichita

70300

Assaf Harofeh Medical Center, Zrifin

77030

The Methodist Hospital Neurological Institute, Houston

79106

Neurologische Universitatsklinik und Poliklinik - Neurzentrum, Freiburg im Breisgau

81675

Neurologische Klinik, Klinikum Rechts Der Isar Der Tu Munchen, München

84101

Soroka University Medical Center, Beersheba

90024

UCLA Stroke Network, Los Angeles

91120

Hadassah University Hospital, Jerusalem

94109

San Francisco Clinical Research Center, San Francisco

06102

The Stroke Center at Hartford Hospital, Hartford

01655

University of Massachusetts, Memorial Health Center, Department of Neurology, Worcester

08629

St. Francis Medical Center, Trenton

B-1070

Hopital Erasme - Dept. of Neurology, Universite Libre de Bruxelles, Brussels

D-45147

Universitatsklinikum Essen, Department of Neurology, Essen

04103

Universitatsklinikum Leipzig Aor, Klinik And Poliklinok Fur Neurologie, Leipzig

40-752

Centralny Szpital Kliniczny, Katowice

31-503

Collegium Medicum Jegiellonian University, Krakow

00-909

Military Institute of Medicine, Warsaw

08916

Hospital Universitari Germans Trias i Pujol, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Daiichi Sankyo

INDUSTRY

NCT00272909 - Efficacy of SUN N4057 in Subjects With Acute Ischemic Stroke and Measurable Penumbra on Magnetic Resonance Imaging (MRI) | Biotech Hunter | Biotech Hunter